Pediatric Oncology Position / Solid Tumor Program Director

Salary depends on experience
Posted on 11/08/17
Patient Care
Salary depends on experience
Posted on 11/08/17

The Division of Hematology/Oncology/Bone Marrow Transplantation at Children's Mercy Kansas City is recruiting for an academic board certified Pediatric Hematology/Oncology physician at the Assistant, Associate or Full Professor level who will join the Section of Oncology with the opportunity to lead the Solid Tumor program in the Children's Mercy Cancer Center.  The Division is made up of 29 total physicians who focus in one of 4 areas – Oncology, Hematology, Bone Marrow Transplantation, or Inpatient Hem/Onc Hospitalist care.  Within the section of Oncology there are 12 physicians with varying levels of clinical, research, and programmatic leadership responsibility.  Clinically, each Oncologist is teamed with an Advanced Nurse Practitioner and a Social Worker in the oversight of their primary patients.  Children's Mercy sees over 200 newly diagnosed children annually between the ages of 0 and 21 years of age and, now teaming with the University of Kansas Cancer Center as a Consortium member institution in its NCI Cancer Center designation, the potential to see older patients with childhood solid tumors is available.  Outpatient clinic facilities include 14 infusion bays and 18 exam rooms wholly dedicated to Hem/Onc.  The inpatient unit has fully hepafiltered 38 private patient rooms and floor where all Hem/Onc patients are admitted.  Inpatients are overseen by 4 Hem/Onc services – an inpatient resident/fellow H/O service, 1 chemo service, 1 BMT service, and 1 inpatient coagulation consultation service – all staffed by residents and/or advanced practice professionals.  All medical, pathology, radiologic and surgical subspecialties are represented in CM who work closely in the care of children with cancer.

 

The Children's Mercy Cancer Center is composed of physicians from multiple medical and surgical specialties and together make up various patient-specific (Survivors, Hispanic, AYA, etc), therapy-specific (Phase I, BMT, etc), and tumor-specific (Hematologic, CNS, Sarcoma, Solid tumor, etc) programs.  Each program is led by a Program Director who works with their multi-specialty, multi-discipline teams to establish strong clinical, research, and education focused goal-driven efforts.  Clinical and laboratory research programs are available both at CMKC and the KUCC campuses as well as our 3rd Consortium partner institution – Stowers Medical Research Institute – a basic science research institution. The Children's Mercy Research Institute is expanding this Fall 2017 with the start of construction on a new 9 story research building that will include wet and dry labs including a GMP facility and vivarium.   Further support of cancer research at Children's Mercy includes our Cancer Genomics program, our Tumor Biorepository, and the Children's Mercy Division of Clinical Pharmacology with active research in cancer pharmacogenomics.  Research is actively supported by a variety of sources including NIH, Foundations, Philanthropic, and Institutional grant mechanisms strongly enhanced by our Research Administration.  The candidate should have a clinical and research (laboratory or clinical) focus in the childhood solid tumors and have a desire and skill set to direct the growth of the Solid Tumor program in collaboration with other programs at CMKC, the KUCC, and nationally.  Support will be provided to ensure the candidate's successful pursuit of these goals.  

Not the right job?
Join Ladders to find it.
With a free Ladders account, you can find the best jobs for you and be found by over 20,0000 recruiters.